Audio pioneer Dolby Laboratories (DLB) has made significant strides recently. The company has partnered with brands such as ...

The Lady Lakers hosted the South Prairie-Max Royals at the dock for some region 3 basketball action. The Royals held a 17 ...

We are neutral on Dolby Labs due to limited upside potential despite revenue growth and strong balance sheet in FQ1 2025. Read an analysis of DLB stock here.

Type a few symbols and Take a Trial. The signals for these will appear immediately on your My Stocks Page; add more too.

Data from the first 16 weeks of the open-label extension phase of the RewinD-LB trial are expected in 1Q 2025 and will include data from participants who have received capsules from a more recently ma ...

Dolby Laboratories (DLB) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.

Dolby Laboratories Inc (NYSE:DLB) is set to release its Q1 2025 earnings on Jan 29, 2025. The consensus estimate for Q1 2025 revenue is $346.15 million, and the earnings are expected to come in at $0.

Q1 2025 Earnings Call Transcript January 29, 2025 Dolby Laboratories, Inc. beats earnings expectations. Reported EPS is $1.14 ...

Dolby Laboratories (NYSE:DLB – Get Free Report) will likely be posting its quarterly earnings results after the market closes ...

About Dementia with Lewy Bodies (DLB) DLB is the third most common degenerative disease of the brain (after Alzheimer’s disease and Parkinson’s disease), with approximately 700,000 individuals ...